Circulation Research, Vol 65, 657-670, Copyright © 1989 by American Heart Association

ARTICLES

Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis

IJ Benjamin, JE Jalil, LB Tan, K Cho, KT Weber and WA Clark
Cardiovascular Institute, Michael Reese Hospital, Chicago, Illinois.

Treatment of rats with the beta-adrenergic agonist isoproterenol results in cardiac hypertrophy, myocyte necrosis, and interstitial cell fibrosis. Our objectives in this study have been to examine whether hypertrophy and fibrosis occur in a compensatory and reparative response to myocyte loss or whether either process may be occurring independently of myocyte loss and thus be a reactive response to adrenergic hormone stimulation. We have examined this question by evaluating each of these responses in rats treated with different doses and forms of isoproterenol administration. Myocyte necrosis was evaluated using in vivo labeling with monoclonal antimyosin for identification of myocytes with permeable sarcolemma, which was indicative of irreversible injury. Myocardial fibrosis was evaluated by morphometric point counting of Gomori-stained tissue sections and by assessment of the stimulation of fibroblast proliferation by determination of increased levels of DNA synthesis. Stimulation of fibroblast DNA synthesis was determined from DNA specific radioactivities and radioautography after pulse labeling with [3H]thymidine. The evidence provided by this study suggests that the degree and timing of myocardial hypertrophy does not follow the course of myocyte loss and, thus, appears to be either a response to altered cardiac loading or a reactive response to beta-adrenergic hormone stimulation rather than a compensation for myocyte loss. Myocardial fibrosis, on the other hand, appears to be more closely related to myocyte necrosis with respect to collagen accumulation in the same areas of the heart, its dose-response relation to the amount of isoproterenol administered, and the timing of increased DNA synthesis, or fibroblast proliferation, after myocyte loss.

This article has been cited by other articles:

				M Anderson, D Moore, and D. Larson Comparison of isoproterenol and dobutamine in the induction of cardiac hypertrophy and fibrosis Perfusion, July 1, 2008; 23(4): 231 - 235. [Abstract] [PDF]

				A. P. C. Davel, L. E. Fukuda, L. L. De Sa, C. D. Munhoz, C. Scavone, D. Sanz-Rosa, V. Cachofeiro, V. Lahera, and L. V. Rossoni Effects of isoproterenol treatment for 7 days on inflammatory mediators in the rat aorta Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H211 - H219. [Abstract] [Full Text] [PDF]

				A. J. Serra, M. L. Higuchi, S. S.M. Ihara, E. L. Antonio, M. H.H. Santos, M. T.N.M. Bombig, and P. J.F. Tucci Exercise training prevents {beta}-adrenergic hyperactivity-induced myocardial hypertrophy and lesions Eur J Heart Fail, June 1, 2008; 10(6): 534 - 539. [Abstract] [Full Text] [PDF]

				O. Sorop, D. Merkus, V. J. de Beer, B. Houweling, A. Pistea, E. O. McFalls, F. Boomsma, H. M. van Beusekom, W. J. van der Giessen, E. VanBavel, et al. Functional and Structural Adaptations of Coronary Microvessels Distal to a Chronic Coronary Artery Stenosis Circ. Res., April 11, 2008; 102(7): 795 - 803. [Abstract] [Full Text] [PDF]

				G. S. Lynch and J. G. Ryall Role of {beta}-Adrenoceptor Signaling in Skeletal Muscle: Implications for Muscle Wasting and Disease Physiol Rev, April 1, 2008; 88(2): 729 - 767. [Abstract] [Full Text] [PDF]

				W. S. Park, J.-H. Ko, N. Kim, Y. K. Son, S. H. Kang, M. Warda, I. D. Jung, Y.-M. Park, and J. Han Increased Inhibition of Inward Rectifier K+ Channels by Angiotensin II in Small-Diameter Coronary Artery of Isoproterenol-Induced Hypertrophied Model Arterioscler Thromb Vasc Biol, August 1, 2007; 27(8): 1768 - 1775. [Abstract] [Full Text] [PDF]

				M. York, C. Scudamore, S. Brady, C. Chen, S. Wilson, M. Curtis, G. Evans, W. Griffiths, M. Whayman, T. Williams, et al. Characterization of Troponin Responses in Isoproterenol-Induced Cardiac Injury in the Hanover Wistar Rat Toxicol Pathol, June 1, 2007; 35(4): 606 - 617. [Abstract] [Full Text] [PDF]

				O. E. Osadchii, G. R. Norton, R. McKechnie, D. Deftereos, and A. J. Woodiwiss Cardiac dilatation and pump dysfunction without intrinsic myocardial systolic failure following chronic beta-adrenoreceptor activation Am J Physiol Heart Circ Physiol, April 1, 2007; 292(4): H1898 - H1905. [Abstract] [Full Text] [PDF]

				T. A. Baudino, W. Carver, W. Giles, and T. K. Borg Cardiac fibroblasts: friend or foe? Am J Physiol Heart Circ Physiol, September 1, 2006; 291(3): H1015 - H1026. [Abstract] [Full Text] [PDF]

				D. L. Miller, P. Li, C. Dou, D. Gordon, C. A. Edwards, and W. F. Armstrong Influence of Contrast Agent Dose and Ultrasound Exposure on Cardiomyocyte Injury Induced by Myocardial Contrast Echocardiography in Rats Radiology, October 1, 2005; 237(1): 137 - 143. [Abstract] [Full Text] [PDF]

				H. Tsuneyoshi, W. Oriyanhan, H. Kanemitsu, R. Shiina, T. Nishina, S. Matsuoka, T. Ikeda, and M. Komeda Does the {beta}2-Agonist Clenbuterol Help to Maintain Myocardial Potential to Recover During Mechanical Unloading? Circulation, August 30, 2005; 112(9_suppl): I-51 - I-56. [Abstract] [Full Text] [PDF]

				M. D. Faulx, P. Ernsberger, D. Vatner, R. D. Hoffman, W. Lewis, R. Strachan, and B. D. Hoit Strain-dependent {beta}-adrenergic receptor function influences myocardial responses to isoproterenol stimulation in mice Am J Physiol Heart Circ Physiol, July 1, 2005; 289(1): H30 - H36. [Abstract] [Full Text] [PDF]

				P. Gregorevic, J. G. Ryall, D. R. Plant, M. N. Sillence, and G. S. Lynch Chronic {beta}-agonist administration affects cardiac function of adult but not old rats, independent of {beta}-adrenoceptor density Am J Physiol Heart Circ Physiol, July 1, 2005; 289(1): H344 - H349. [Abstract] [Full Text] [PDF]

				C.-K. Yeh, P. M. Ghosh, H. Dang, Q. Liu, A. L. Lin, B.-X. Zhang, and M. S. Katz {beta}-Adrenergic-responsive activation of extracellular signal-regulated protein kinases in salivary cells: role of epidermal growth factor receptor and cAMP Am J Physiol Cell Physiol, June 1, 2005; 288(6): C1357 - C1366. [Abstract] [Full Text] [PDF]

				G.-X. Zhang, S. Kimura, A. Nishiyama, T. Shokoji, M. Rahman, L. Yao, Y. Nagai, Y. Fujisawa, A. Miyatake, and Y. Abe Cardiac oxidative stress in acute and chronic isoproterenol-infused rats Cardiovasc Res, January 1, 2005; 65(1): 230 - 238. [Abstract] [Full Text] [PDF]

				T. Ohta, N. Hasebe, S. Tsuji, K. Izawa, Y.-T. Jin, S. Kido, S. Natori, M. Sato, and K. Kikuchi Unequal effects of renin-angiotensin system inhibitors in acute cardiac dysfunction induced by isoproterenol Am J Physiol Heart Circ Physiol, December 1, 2004; 287(6): H2914 - H2921. [Abstract] [Full Text] [PDF]

				Z. Y. Fang, J. B. Prins, and T. H. Marwick Diabetic Cardiomyopathy: Evidence, Mechanisms, and Therapeutic Implications Endocr. Rev., August 1, 2004; 25(4): 543 - 567. [Abstract] [Full Text] [PDF]

				D. F. Goldspink, J. G. Burniston, G. M. Ellison, W. A. Clark, and L.-B. Tan Catecholamine-induced apoptosis and necrosis in cardiac and skeletal myocytes of the rat in vivo: the same or separate death pathways? Exp Physiol, July 1, 2004; 89(4): 407 - 416. [Abstract] [Full Text] [PDF]

				R. Bos, N. Mougenot, O. Mediani, P. M. Vanhoutte, and P. Lechat Potassium Canrenoate, an Aldosterone Receptor Antagonist, Reduces Isoprenaline-Induced Cardiac Fibrosis in the Rat J. Pharmacol. Exp. Ther., June 1, 2004; 309(3): 1160 - 1166. [Abstract] [Full Text] [PDF]

				T. Costoli, A. Bartolomucci, G. Graiani, D. Stilli, G. Laviola, and A. Sgoifo Effects of chronic psychosocial stress on cardiac autonomic responsiveness and myocardial structure in mice Am J Physiol Heart Circ Physiol, June 1, 2004; 286(6): H2133 - H2140. [Abstract] [Full Text] [PDF]

				R. Van Kerckhoven, R. van Veghel, P. R Saxena, and R. G Schoemaker Pharmacological therapy can increase capillary density in post-infarction remodeled rat hearts Cardiovasc Res, February 15, 2004; 61(3): 620 - 629. [Abstract] [Full Text] [PDF]

				M. P. Ocaranza, G. Diaz-Araya, J. E. Carreno, D. Munoz, J. P. Riveros, J. E. Jalil, and S. Lavandero Polymorphism in gene coding for ACE determines different development of myocardial fibrosis in rats Am J Physiol Heart Circ Physiol, February 1, 2004; 286(2): H498 - H506. [Abstract] [Full Text] [PDF]

				A. Zahabi, S. Picard, N. Fortin, T. L. Reudelhuber, and C. F. Deschepper Expression of Constitutively Active Guanylate Cyclase in Cardiomyocytes Inhibits the Hypertrophic Effects of Isoproterenol and Aortic Constriction on Mouse Hearts J. Biol. Chem., November 28, 2003; 278(48): 47694 - 47699. [Abstract] [Full Text] [PDF]

				N. Kim, J. Chung, E. Kim, and J. Han Changes in the Ca2+-Activated K+ Channels of the Coronary Artery During Left Ventricular Hypertrophy Circ. Res., September 19, 2003; 93(6): 541 - 547. [Abstract] [Full Text] [PDF]

				I. L. Ennis, E. M. Escudero, G. M. Console, G. Camihort, C. G. Dumm, R. W. Seidler, M. C. Camilion de Hurtado, and H. E. Cingolani Regression of Isoproterenol-Induced Cardiac Hypertrophy by Na+/H+ Exchanger Inhibition Hypertension, June 1, 2003; 41(6): 1324 - 1329. [Abstract] [Full Text] [PDF]

				J. G. Burniston, Y. Ng, W. A. Clark, J. Colyer, L.-B. Tan, and D. F. Goldspink Myotoxic effects of clenbuterol in the rat heart and soleus muscle J Appl Physiol, November 1, 2002; 93(5): 1824 - 1832. [Abstract] [Full Text] [PDF]

				E. A. Bua, S. H. McKiernan, J. Wanagat, D. McKenzie, and J. M. Aiken Mitochondrial abnormalities are more frequent in muscles undergoing sarcopenia J Appl Physiol, June 1, 2002; 92(6): 2617 - 2624. [Abstract] [Full Text] [PDF]

				T Kohnlein, T Welte, L B Tan, and M W Elliott Central sleep apnoea syndrome in patients with chronic heart disease: a critical review of the current literature Thorax, June 1, 2002; 57(6): 547 - 554. [Abstract] [Full Text] [PDF]

				J. WANAGAT, Z. CAO, P. PATHARE, and J. M. AIKEN Mitochondrial DNA deletion mutations colocalize with segmental electron transport system abnormalities, muscle fiber atrophy, fiber splitting, and oxidative damage in sarcopenia FASEB J, February 1, 2001; 15(2): 322 - 332. [Abstract] [Full Text] [PDF]

				M. Jain, C. C. Lim, K. Nagata, V. M. Davis, D. S. Milstone, R. Liao, and R. M. Mortensen Targeted inactivation of G{alpha}i does not alter cardiac function or {beta}-adrenergic sensitivity Am J Physiol Heart Circ Physiol, February 1, 2001; 280(2): H569 - H575. [Abstract] [Full Text] [PDF]

				K. T Weber and Yao Sun Recruitable ACE and tissue repair in the infarcted heart Journal of Renin-Angiotensin-Aldosterone System, December 1, 2000; 1(4): 295 - 303. [PDF]

				X.-J. Du, D. J. Autelitano, R. J. Dilley, B. Wang, A. M. Dart, and E. A. Woodcock {beta}2-Adrenergic Receptor Overexpression Exacerbates Development of Heart Failure After Aortic Stenosis Circulation, January 4, 2000; 101(1): 71 - 77. [Abstract] [Full Text] [PDF]

				S. Guerra, A. Leri, X. Wang, N. Finato, C. Di Loreto, C. A. Beltrami, J. Kajstura, and P. Anversa Myocyte Death in the Failing Human Heart Is Gender Dependent Circ. Res., October 29, 1999; 85(9): 856 - 866. [Abstract] [Full Text] [PDF]

				D J Wright and L B Tan Classic techniques in medicine: The role of exercise testing in the evaluation and management of heart failure Postgrad. Med. J., August 1, 1999; 75(886): 453 - 458. [Abstract] [Full Text]

				A. Frustaci, C. Chimenti, M. Setoguchi, S. Guerra, S. Corsello, F. Crea, A. Leri, J. Kajstura, P. Anversa, and A. Maseri Cell Death in Acromegalic Cardiomyopathy Circulation, March 23, 1999; 99(11): 1426 - 1434. [Abstract] [Full Text] [PDF]

				Y.-J. Geng, Y. Ishikawa, D. E. Vatner, T. E. Wagner, S. P. Bishop, S. F. Vatner, and C. J. Homcy Apoptosis of Cardiac Myocytes in Gs{alpha} Transgenic Mice Circ. Res., January 22, 1999; 84(1): 34 - 42. [Abstract] [Full Text] [PDF]

				I. J. Benjamin and D. R. McMillan Stress (Heat Shock) Proteins : Molecular Chaperones in Cardiovascular Biology and Disease Circ. Res., July 27, 1998; 83(2): 117 - 132. [Abstract] [Full Text] [PDF]

				K. Wong, K. R Boheler, J. Bishop, M. Petrou, and M. H Yacoub Clenbuterol induces cardiac hypertrophy with normal functional, morphological and molecular features Cardiovasc Res, January 1, 1998; 37(1): 115 - 122. [Abstract] [Full Text] [PDF]

				K. T. Weber Extracellular Matrix Remodeling in Heart Failure : A Role for De Novo Angiotensin II Generation Circulation, December 2, 1997; 96(11): 4065 - 4082. [Full Text]

				B. Li, Q. Li, X. Wang, K. P. Jana, G. Redaelli, J. Kajstura, and P. Anversa Coronary constriction impairs cardiac function and induces myocardial damage and ventricular remodeling in mice Am J Physiol Heart Circ Physiol, November 1, 1997; 273(5): H2508 - H2519. [Abstract] [Full Text] [PDF]

				K. Wong, K. R. Boheler, M. Petrou, and M. H. Yacoub Pharmacological Modulation of Pressure-Overload Cardiac Hypertrophy : Changes in Ventricular Function, Extracellular Matrix, and Gene Expression Circulation, October 7, 1997; 96(7): 2239 - 2246. [Abstract] [Full Text]

				G. Olivetti, R. Abbi, F. Quaini, J. Kajstura, W. Cheng, J. A. Nitahara, E. Quaini, C. Di Loreto, C. A. Beltrami, S. Krajewski, et al. Apoptosis in the Failing Human Heart N. Engl. J. Med., April 17, 1997; 336(16): 1131 - 1141. [Abstract] [Full Text] [PDF]

				M. Iwase, S. P. Bishop, M. Uechi, D. E. Vatner, R. P. Shannon, R. K. Kudej, D. C. Wight, T. E. Wagner, Y. Ishikawa, C. J. Homcy, et al. Adverse Effects of Chronic Endogenous Sympathetic Drive Induced by Cardiac Gs{alpha} Overexpression Circ. Res., April 1, 1996; 78(4): 517 - 524. [Abstract] [Full Text]

				A. Toet, J. te Biesebeek, W. Vleeming, J. Wemer, J. Meulenbelt, and D. de Wildt Reduced survival after isoprenaline/ dopamine in d,l-propranolol intoxicated rats Human and Experimental Toxicology, February 1, 1996; 15(2): 120 - 128. [Abstract] [PDF]

				C. L. Antos, N. Frey, S. O. Marx, S. Reiken, M. Gaburjakova, J. A. Richardson, A. R. Marks, and E. N. Olson Dilated Cardiomyopathy and Sudden Death Resulting From Constitutive Activation of Protein Kinase A Circ. Res., November 23, 2001; 89(11): 997 - 1004. [Abstract] [Full Text] [PDF]